Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Elixirgen Therapeutics, Inc., explained in plain language.
This early-stage study is testing the safety of an experimental cell therapy called EXG34217 in people with genetic disorders that cause bone marrow failure. The therapy involves collecting a patient's own blood cells, modifying them in a lab to potentially lengthen their telomer…
Phase: PHASE1 • Sponsor: Elixirgen Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC